| |
GAM technology utilizing well characterized growth factor or cytokine genes circumvents the protein delivery and maintenance hurdles in tissue repair and regeneration indications.
GAM provides a method of targeting repair and progenitor cells. Any biocompatible matrix, natural or synthetic, may be used; the formulation selected will depend upon the local environment and the particular clinical indication.
|
|
Tissue Repair Company (TRC) is a San Diego biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is broadly based in gene therapy, growth factor biology, tissue regeneration and product development.
 |
Tissue Repair Company’s
clinical targets:
Dermal Wound Repair
(e.g. diabetic ulcers,
pressure ulcers, venous stasis ulcers) |
|
Hard Tissue Repair
(e.g. spinal fusion, long bone fractures, cartilage repair)
Therapeutic Angiogenesis
(e.g. peripheral arterial disease, cardiovascular ischemia) |
 |
|
|
Tissue Repair Company
IN THE NEWS
of news coverage of Excellarate Trial in
San Diego, CA.
View more videos. |
|
|
|
|
|
